The decision to part ways with our previous auditors, Turner, Stone & Company, L.L.P. (T&S), was ratified by our Board of Directors on February 9, 2024. It's imperative to note that this change was necessitated by a series of challenges, including delays and disagreements which we believe were not in the best interest of our company and its stakeholders. Despite our efforts to resolve these matters, it became clear that a change was necessary to uphold our commitment to the highest standards of accuracy, transparency, and accountability in our financial reporting.

The engagement of VMCPA marks a significant milestone in Endexx’s journey. Finding a new auditor under such circumstances was a challenging endeavor, reflecting our determination to align with partners who share our values and commitment to excellence. VMCPA brings a fresh perspective and a high level of expertise that we believe will be instrumental in our continued growth and success.

This auditor transition is one of many steps we are taking to strengthen our corporate governance, enhance operational efficiencies, and drive sustainable growth. We are confident that this change aligns with our strategic goals and the long-term interests of our shareholders.

Endexx Corporation is on a path of strategic evolution, with a focus on expanding our market reach, enhancing our product offerings, and delivering value to our shareholders. We are committed to navigating these changes with integrity, transparency, and a forward-looking approach.

We appreciate the patience and support of our shareholders during this transition period. Endexx looks forward to a future filled with opportunity, growth, and innovation. Stay tuned for more updates as we continue to advance our mission of delivering high-quality, plant-based wellness products to consumers worldwide.

About Endexx Corporation

Endexx Corporation develops and distributes all-natural, plant-derived wellness products and topical skincare products.  Its products vary from balms, creams, lotions, butter, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness.  The science behind these products involves a decade of clinical research in the field and lab work to provide a functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

Hyla currently markets its proprietary non-nicotine, guarana, and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.com

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief, or current expectations of the Company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements.  Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions, and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful before registration or qualification under the securities laws of any such jurisdiction.  No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.

For further details, please contact:
Endexx Corporation
IR@Endexx.com